Colgate-Palmolive Company (NYSE:CL) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Colgate-Palmolive Company (NYSE:CLGet Free Report) have received a consensus rating of “Moderate Buy” from the sixteen ratings firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and ten have assigned a buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $88.8125.

A number of analysts have recently issued reports on the company. UBS Group dropped their target price on Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating on the stock in a research report on Monday, November 3rd. Evercore ISI dropped their price objective on Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating on the stock in a report on Monday, November 3rd. The Goldman Sachs Group decreased their price target on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a research report on Thursday, October 2nd. Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price target on the stock in a report on Tuesday, December 9th. Finally, Citigroup reduced their price objective on shares of Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating on the stock in a research note on Monday, November 3rd.

View Our Latest Stock Report on CL

Colgate-Palmolive Trading Down 0.6%

CL opened at $79.02 on Friday. The firm’s 50 day moving average is $78.53 and its 200-day moving average is $82.41. Colgate-Palmolive has a 52-week low of $74.54 and a 52-week high of $100.18. The company has a quick ratio of 0.60, a current ratio of 0.93 and a debt-to-equity ratio of 5.90. The firm has a market capitalization of $63.70 billion, a P/E ratio of 22.13, a P/E/G ratio of 5.63 and a beta of 0.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its earnings results on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. During the same period in the prior year, the firm earned $0.91 earnings per share. The business’s quarterly revenue was up 1.9% compared to the same quarter last year. Analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.26%.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of CL. Westside Investment Management Inc. raised its position in shares of Colgate-Palmolive by 85.5% during the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after acquiring an additional 130 shares in the last quarter. Saudi Central Bank acquired a new stake in shares of Colgate-Palmolive during the first quarter worth $29,000. Copia Wealth Management acquired a new stake in shares of Colgate-Palmolive during the third quarter worth $29,000. Vermillion & White Wealth Management Group LLC lifted its position in shares of Colgate-Palmolive by 86.1% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after buying an additional 155 shares during the last quarter. Finally, Cloud Capital Management LLC acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at about $30,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

(Get Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Featured Stories

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.